-
Medical and technological advances have addressed some important concerns
BY JOHN SCHIESZER
Clinicians historically have been wary of performing various aesthetic procedures such as chemical peeling and laser resurfacing in darker-skinned individual...
-
Owners react to declining demand for cosmetic services with various promotional strategies
BY JOHN SCHIESZER
During this time of economic crisis when many people are seeing their investments dramatically dwindle, a different type of belt tightening is ...
-
More and more treatment centers are offering this controversial treatment, despite not being approved by the FDA for fat removalBY JOHN SCHIESZER Overweight and obese people often seek a medical means for removing fat. This desire has made li...
-
Adapalene 0.1% plus benzoyl peroxide 2.5% found to give better results BY JOHN SCHIESZER PARIS—Adapalene 0.1% and benzoyl peroxide 2.5% combination gel (Epiduo) may be superior to the individual ingredients and gel vehicle, accord...
-
Software Complies with Updated Interoperability RequirementsJune 26 – The Certification Commission for Healthcare Information Technology (CCHIT®) today announced that NexTech’s product Practice 2010 9.3 is a CCHIT Certified® 08 Ambulatory EHR, and m...
-
Memphis, TN, June 24 -- The Theraplex Company, makers of the Theraplex line of medical moisturizers, unveiled the new theraplex SA FACIAL PEEL last week at the Cosmetic Boot Camp in Aspen, Colorado. It sparked a lot of excitement among dermatologists atte...
-
Burlington, MA. -- Palomar Medical Technologies Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced that it has become the first company to receive a 510(k) over-the-counter (OTC) clear...
-
Allergan, Inc. (NYSE:AGN) today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's Supplemental Biologics License Application (sBLA) for BOTOX® (Botulinum Toxin Type A) to treat u...
-
Oceanside, N.Y. -- May 18 /PRNewswire/ -- Ellman International, Inc. announced today that the Food and Drug Administration (FDA) has granted clearance to Pelleve(TM), a skin tightening system for the non-ablative treatment of mild to moderate facial wrink...
-
Louisville, CO -- May 19 /PRNewswire/ -- Despite the current economic recession, physician and patient demand for the VASER(R) Lipo body contouring procedure continues to accelerate at healthy rates. Sound Surgical Technologies LLC, creator of the VASER(R...
-
Burlington, MA-- May 11 -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, announced today that it has entered into a Distribution Agreement with Quantel SA (Euronext: ...
-
Study Results Demonstrate that (Lidocaine 4% Foam) Reduces Pain Associated with Common Dermatologic ProceduresCumberland, RI -- May 4 – Results from an open label study assessing the reduction in Procedure-Associated Pain with the use of a lidocai...
-
N. Dallas, TX and Plano, TX -- April 30 -- The battle for beauty now goes wrinkle-to-wrinkle, as Botox's rival, Dysport(TM), has received FDA clearance and is expected to begin their challenge to Botox(R) sometime within the next sixty days. The arrival o...
-
May 1, 2009 - Biopelle, Inc., a Ferndale Pharma Group company, introduces Tensage, a unique new fibroblast growth factor line. Tensage utilizes the patented SCA Biorepair Technology to slow and reverse the visible signs of aging.
...
-
Scientists testing a cosmetic anti-ageing product sold on the high street have shown it can clinically reduce wrinkles and improve the appearance of skin damaged by everyday exposure to sunlight.Dermatologists at The University of Manchester carried out a...
-
Natural embryonic-like human proteins stimulate skin cells to combat aging and help support healing San Diego, Ca – Histogen Aesthetics, a division of Histogen focused on providing unique, clinically proven, human skin cell-derived products for aesthet...
-
Rockville, MD – April 7, 2009 - Glycotex, Inc. today announced the completion of a scheduled interim analysis in a Phase II study evaluating the effect of investigational GLYC-101 gel on complete wound closure and cosmetic outcomes in cosmetic surgery p...
-
The drug avotermin (Juvista) could provide accelerated and permanent improvement in scarring following injuries. The findings are reported in an Article in this week's Lancet, written by Professor Mark Ferguson, University of Manchester, UK, and Renovo, M...
-
Astellas Pharma Europe Ltd announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion, recommending the approval of a twice-weekly application regimen of Protopic® ointme...
-
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration (FDA) has approved Vectical(TM) (calcitriol) Ointment 3mcg/g, a unique vitamin D3 product for the treatment of mild-to-moderate plaque psoriasis in adults. Psoriasis is a chr...
